Abstract : NKG2D mediates an important costimulatory pathway in CD8 T cells. In HIV infection, the authors found that NKG2D expression on both total CD8 and HIV-specific CD8 T cells was significantly lower in viremic patients than in HIV controllers. Antiretroviral therapy partially restored NKG2D expression on HIV-specific CD8 T cells. The authors observed a negative correlation between the respective expression levels of CD38 and NKG2D on total CD8 and HIV-specific CD8 T cells. The maintenance of NKG2D expression on CD8 T cells in HIV controllers may contribute to better cell function.
https://hal-pasteur.archives-ouvertes.fr/pasteur-01420533
Contributor : Marie-Genevieve Guibert
<>
Submitted on : Tuesday, May 16, 2017 - 1:15:29 PM
Last modification on : Friday, April 26, 2019 - 3:55:11 PM
Long-term archiving on : Friday, August 18, 2017 - 12:15:09 AM
Camille Lecuroux, Asier Saez-Cirion, Nicolas Noel, Lilia Ben-Lamine, Isabelle Girault, et al.. NKG2D expression on HIV-specific CD8+ T cells is reduced in viremic HIV-1-infected patients but maintained in HIV controllers. Journal of Acquired Immune Deficiency Syndromes, Lippincott, Williams & Wilkins, 2013, 62 (1), pp.17--20. ⟨10.1097/QAI.0b013e318274579f⟩. ⟨pasteur-01420533⟩
